Physician Assistant · Detroit, MI
NPI
1780051227
Since 2015
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
261 Mack Ave Ste 215
Detroit, MI, 48201
Phone (313) 966-2539
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,437
139 services
Medicare patients, 2024
98
Average age 72
Drug cost, 2024
$323K
902 prescriptions
Company payments, 2025
$3,142
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vanessa Delgado was code 99213 (office e&m - established), 71 times for 61 patients. In total Vanessa Delgado billed 139 services in 6 codes, and Medicare paid $9,437.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 71 | 61 | $57.47 | $4,080 |
| 99214 Office E&M - Established | Office | 34 | 27 | $78.24 | $2,660 |
| 99204 Office E&M - New | Office | 16 | 16 | $108.01 | $1,728 |
By year: 2023 $8,186 for 129 services; 2024 $9,437 for 139 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vanessa Delgado prescribed most often to Medicare patients was Omeprazole, with 163 prescriptions and refills. In total Vanessa Delgado wrote 902 Medicare prescriptions that cost $323K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 163 | 344 | 102 | $1,886 |
| Famotidine Generic | 152 | 366 | 86 | $2,380 |
| Sucralfate Generic | 87 | 114 | 49 | $3,935 |
| Dicyclomine Hcl Generic | 48 | 72 | 34 | $1,038 |
| Pantoprazole Sodium Generic | 47 | 117 | 24 | $366 |
| Esomeprazole Magnesium Generic | 41 | 103 | 21 | $1,579 |
| Linzess Linaclotide | 32 | 66 | 17 | $35K |
| Metronidazole Generic | 26 | 26 | 26 | $193 |
| Metoclopramide Hcl Generic | 25 | 29 | 15 | $226 |
| Amitriptyline Hcl Generic | 21 | 23 | Under 11 | $176 |
| Bismuth-Metronidazole-Tetracyc Bismuth/Metronid/Tetracycline | 17 | 17 | 16 | $12K |
| Xifaxan Rifaximin | 16 | 16 | Under 11 | $50K |
| Ibsrela Tenapanor Hcl | 15 | 19 | Under 11 | $32K |
| Ondansetron Odt Ondansetron | 13 | 13 | 12 | $247 |
| Talicia Omeprazole/Amoxicill/Rifabutin | 11 | 11 | 11 | $8,347 |
Brand drugs: 161 claims; generic drugs: 741 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vanessa Delgado $3,142 ($3,142 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $908.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 51 | $908 |
| Madrigal Pharmaceuticals MDGL | 30 | $895 |
| Janssen Biotech, Inc. JNJ | 12 | $338 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $215 |
| Celltrion USA Inc. 068270.KS | 7 | $201 |
| Braintree Laboratories, Inc. | 8 | $183 |
| Ardelyx, Inc. ARDX | 5 | $117 |
| Pfizer Inc. PFE | 4 | $81.63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $67.34 |
| Evoke Pharma, Inc. EVOK | 2 | $37.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.